Rare MBD are less recognized and due to its rarity, often associated with delayed diagnosis. Metabolic bone disease is the third most common endocrine disorders after diabetes and thyroid diseases. The common metabolic bone diseases (MBD) include osteoporosis, rickets/ osteomalacia, flurosis and primary hyperparathyroidism (PHPT), while the rare MBDs include Paget’s disease, tumor induced osteomalacia, fibrous dysplasia, osteogenesis imperfecta and so on.
About Us
The purpose of Indian Rare Metabolic Bone Disorders (RMBD) registry is to help medical personals and researchers in better understanding of the disease and apply them into better patient care. More specifically the objectives of this registry program are as follows:
- Maintain clinical, biochemical, haematological and radiological profile of patients diagnosed with RMBD
- Changes in symptoms, biochemical parameters and complications over the time after diagnosis and treatment.
- To evaluate current status of the Metabolic Bone Disorders, complications and curative practices applied by clinicians in disease subjects in India.
- To access disease incidence in India and mortality rates of patients with RMBD
- Conduct and promote research on Metabolic Bone Disorders using clinical, biochemical and basic science approaches.
The Indian RMBD registry will act as data source of patient information and help in continuing development of patient care in RMBD. Registry program will help endocrinologists, nephrologists, pathologists, radiologists and orthopaedic surgeons in understanding the disease in a better way and apply it in management of the disease.
Dr Sanjay Kumar Bhadada
MD General Medicine, DM (Endocrinology), FRCPI, FAMS
Professor
Department of Endocrinology
Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh